Form 8-K · Current report
Danaher Corporation 8-K, filed Oct 13, 2026
- Filed
- CIK
- 0000313616
- Accession no.
- 0000313616-26-000193
Summary
Danaher expanded its board of directors to thirteen members and appointed Daniel L. Comas, its former CFO, and Robert M. Hershberg, former CEO of HilleVax, as directors effective October 9, 2026, while director Alan G. Spoon notified the company he will retire at the 2027 annual meeting. Separately, chairman and co-founder Steven M. Rales and executive committee chairman and co-founder Mitchell P. Rales waived their rights to restricted stock units covering 500,000 shares each, granted in August 2026, for no consideration.
Key points
- Comas and Hershberg will serve until Danaher's next annual meeting; Hershberg was also named to the board's Science and Technology Committee.
- Comas served as Danaher's CFO from 2005 to 2018 and as a consultant to the company until September 30, 2026, when his consulting agreement was terminated in connection with his board appointment.
- Spoon's retirement is effective at the 2027 annual meeting and is not due to any disagreement with the company.
- The two new directors receive prorated cash compensation and prorated equity awards under Danaher's non-employee director compensation program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 8.01Other Events
From the filing
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS Director Appointments On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately. Each of Mr. Comas and Dr. Hershberg will serve until the Company’s next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal. Dr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.